Facebook Twitter LinkedIn Google Plus RSS

BD gets approval for generic injectable drugs

By ,

Franklin Lakes-based medical technology company BD announced today the U.S. Food and Drug Administration has approved its first drug to be offered in the just-launched BD Simplist line of prefilled generic injectables.

According to BD, Simplist products will be commercialized and manufactured by BD Rx Inc., a wholly owned subsidiary of the company. The first product BD Rx will launch is an injectable antihistamine.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy